Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Benz

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Toxicological and clinical computational analysis and the US FDA/CDERR Daniel Benz
Current Opinion in Critical Care|October 17, 2017
Damage control surgery: current state and future directionsDaniel Benz, Zsolt J Balogh
Journal of Orthopaedic Surgery (Hong Kong)|June 29, 2019
Acute atraumatic bilateral acetabular insufficiency fracturesDaniel Benz, Patrick Lim, Zsolt J Balogh
Injury|June 10, 2020
Proximal femur fracture non-union with or without implant failure: A revision technique with clinical outcomesDaniel Benz, Seth M Tarrant, Zsolt J Balogh
Current Opinion in Drug Discovery & Development|February 1, 2006
Landscape of current toxicity databases and database standardsChihae Yang, R Daniel Benz, Mitchell A Cheeseman
Regulatory Toxicology and Pharmacology : RTP|November 19, 2003
Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indicesJoseph F Contrera, Edwin J Matthews, R Daniel Benz
Orthopedic Reviews|April 16, 2015
Can visual aides influence rehabilitation and length of stay following knee replacement? A randomized controlled studySimon Abson, Benjamin Kenny, Reza Rahim, et al.
Regulatory Toxicology and Pharmacology : RTP|January 9, 2007
A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR databaseEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Regulatory Toxicology and Pharmacology : RTP|November 18, 2004
Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily doseJoseph F Contrera, Edwin J Matthews, Naomi L Kruhlak, et al.
Regulatory Toxicology and Pharmacology : RTP|October 26, 2005
In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR softwareJoseph F Contrera, Edwin J Matthews, Naomi L Kruhlak, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Toxicological and clinical computational analysis and the US FDA/CDERR Daniel Benz
Current Opinion in Critical Care|October 17, 2017
Damage control surgery: current state and future directionsDaniel Benz, Zsolt J Balogh
Journal of Orthopaedic Surgery (Hong Kong)|June 29, 2019
Acute atraumatic bilateral acetabular insufficiency fracturesDaniel Benz, Patrick Lim, Zsolt J Balogh
Injury|June 10, 2020
Proximal femur fracture non-union with or without implant failure: A revision technique with clinical outcomesDaniel Benz, Seth M Tarrant, Zsolt J Balogh
Current Opinion in Drug Discovery & Development|February 1, 2006
Landscape of current toxicity databases and database standardsChihae Yang, R Daniel Benz, Mitchell A Cheeseman
Regulatory Toxicology and Pharmacology : RTP|November 19, 2003
Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indicesJoseph F Contrera, Edwin J Matthews, R Daniel Benz
Orthopedic Reviews|April 16, 2015
Can visual aides influence rehabilitation and length of stay following knee replacement? A randomized controlled studySimon Abson, Benjamin Kenny, Reza Rahim, et al.
Regulatory Toxicology and Pharmacology : RTP|January 9, 2007
A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR databaseEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Regulatory Toxicology and Pharmacology : RTP|November 18, 2004
Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily doseJoseph F Contrera, Edwin J Matthews, Naomi L Kruhlak, et al.
Regulatory Toxicology and Pharmacology : RTP|October 26, 2005
In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR softwareJoseph F Contrera, Edwin J Matthews, Naomi L Kruhlak, et al.
Pageof 4